Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Serum susceptibility of Escherichia coli and its association with patient clinical outcomes. Local targets link to admitted publications; unresolved targets remain external evidence.
Recent advances in understanding enteric pathogenic Escherichia coli
10.1128/cmr.00022-13 · 2013 · External reference
Environmental Escherichia coli: ecology and public health implications-a review
10.1111/jam.13468 · 2017 · External reference
Unresolved reference
2021 · External reference
Pathogenic Escherichia coli
10.1016/j.ijmm.2005.06.008 · 2005 · External reference
Epidemiology of Escherichia coli Bacteremia: A Systematic Literature Review
10.1093/cid/ciaa210 · 2021 · External reference
Mortality in Escherichia coli bloodstream infections: a multinational population-based cohort study
10.1186/s12879-021-06326-x · 2021 · External reference
Complement activation, regulation, and molecular basis for complement-related diseases
10.15252/embj.201591881 · 2015 · External reference
The complement system in regulation of adaptive immunity
10.1038/ni1113 · 2004 · External reference
Complement: Bridging the innate and adaptive immune systems in sterile inflammation
10.1002/jlb.3mir0220-270r · 2020 · External reference
Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins
10.1016/j.molimm.2007.06.005 · 2007 · External reference
The central role of the alternative complement pathway in human disease
10.4049/jimmunol.176.3.1305 · 2006 · External reference
The complement system
10.1007/s00441-010-1034-0 · 2011 · External reference
How Escherichia coli Circumvent Complement-Mediated Killing
10.3389/fimmu.2017.00452 · 2017 · External reference
Bacterial self-defence: how Escherichia coli evades serum killing
10.1111/1574-6968.12419 · 2014 · External reference
Complement evasion by human pathogens
10.1038/nrmicro1824 · 2008 · External reference
Bacterial complement evasion
10.1016/j.molimm.2006.06.011 · 2007 · External reference
Bacteriophage Therapy Increases Complement-Mediated Lysis of Bacteria and Enhances Bacterial Clearance After Acute Lung Infection With Multidrug-Resistant Pseudomonas aeruginosa
10.1093/infdis/jiy678 · 2019 · External reference
Health care—associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections
10.7326/0003-4819-137-10-200211190-00007 · 2002 · External reference
APACHE II: a severity of disease classification system
10.1097/00003246-198510000-00009 · 1985 · External reference
Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study
10.1097/ccm.0000000000000723 · 2015 · External reference
Acute lung injury and acute respiratory distress syndrome
10.4103/0974-2700.58663 · 2010 · External reference
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
10.1186/cc5713 · 2007 · External reference
Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology
10.1111/j.1365-2141.2009.07600.x · 2009 · External reference
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
10.1111/j.1469-0691.2011.03570.x · 2012 · External reference
Detection of Outliers Using Interquartile Range Technique from Intrusion Dataset
10.1007/978-981-10-7563-6_53 · 2018 · External reference
Escherichia coli ST131 Associated with Increased Mortality in Bloodstream Infections from Urinary Tract Source
10.1128/jcm.00199-23 · 2023 · External reference
LOCUST: a custom sequence locus typer for classifying microbial isolates
10.1093/bioinformatics/btx045 · 2017 · External reference
The EnteroBase user’s guide, with case studies on Salmonella transmissions, Yersinia pestis phylogeny, and Escherichia core genomic diversity
10.1101/gr.251678.119 · 2020 · External reference
Large-scale comparative analysis of microbial pan-genomes using PanOCT
10.1093/bioinformatics/bty744 · 2019 · External reference
PanOCT: automated clustering of orthologs using conserved gene neighborhood for pan-genomic analysis of bacterial strains and closely related species
10.1093/nar/gks757 · 2012 · External reference
ClermonTyping: an easy-to-use and accurate in silico method for Escherichia genus strain phylotyping
10.1099/mgen.0.000192 · 2018 · External reference
Interaction of cefotaxime and desacetylcefotaxime against pathogenic bacteria. Assessment with the serum bactericidal test
1984 · External reference
The serum bactericidal test
10.1093/clinids/8.5.803 · 1986 · External reference
Prc Contributes to Escherichia coli Evasion of Classical Complement Mediated Serum Killing
10.1128/iai.00321-12 · 2012 · External reference
Flow cytometry: basic principles and applications
10.3109/07388551.2015.1128876 · 2017 · External reference
Specific and rapid enumeration of viable but nonculturable and viable-culturable gram-negative bacteria by using flow cytometry
10.1128/aem.02932-09 · 2010 · External reference
Complement deficiencies and dysregulation: Pathophysiological consequences, modern analysis, and clinical management
10.1016/j.molimm.2019.08.002 · 2019 · External reference
Complement deficiency states and associated infections
10.1016/j.molimm.2011.05.001 · 2011 · External reference
Assessment and interpretation of bacterial viability by using the LIVE/DEAD BacLight Kit in combination with flow cytometry
10.1128/aem.02750-06 · 2007 · External reference
Critical aspects of using bacterial cell viability assays with the fluorophores SYTO9 and propidium iodide
10.1186/s12866-015-0376-x · 2015 · External reference
Bead-Based Flow-Cytometric Cell Counting of Live and Dead Bacteria.
10.1007/978-1-4939-9199-0_11 · 2019 · External reference
Fluorescence monitoring of antibiotic-induced bacterial damage using flow cytometry
10.1002/(sici)1097-0320(19990301)35:3<235::aid-cyto6>3.0.co;2-0 · 1999 · External reference
Absolute bacterial cell enumeration using flow cytometry
10.1111/jam.13508 · 2017 · External reference
Escherichia coli K-12 (pEGFPluxABCDEamp): a tool for analysis of bacterial killing by antibacterial agents and human complement activities on a real-time basis
10.1002/bio.2435 · 2013 · External reference
On-line determination of serum bactericidal activity using recombinant luminescent bacteria
10.1007/s10517-006-0336-4 · 2006 · External reference
Dynamics of human complement-mediated killing of Klebsiella pneumoniae
10.1165/rcmb.2009-0292oc · 2010 · External reference
A High-throughput Shigella-specific Bactericidal Assay
10.3791/59164-v · 2019 · External reference
A high throughput serum bactericidal assay for antibodies to Haemophilus influenzae type b
10.1186/s12879-016-1808-4 · 2016 · External reference
Increasing the High Throughput of a Luminescence-Based Serum Bactericidal Assay (L-SBA)
2021 · External reference
Development of a high-throughput method to evaluate serum bactericidal activity using bacterial ATP measurement as survival readout
10.1371/journal.pone.0172163 · 2017 · External reference
Development and Characterization of a Luminescence-Based High-Throughput Serum Bactericidal Assay (L-SBA) to Assess Bactericidal Activity of Human Sera against Nontyphoidal Salmonella
10.3390/mps5060100 · 2022 · External reference
Antibodies Elicited by the Shigella sonnei GMMA Vaccine in Adults Trigger Complement-Mediated Serum Bactericidal Activity: Results From a Phase 1 Dose Escalation Trial Followed by a Booster Extension
10.3389/fimmu.2021.671325 · 2021 · External reference
Setup and Characterization of a High-Throughput Luminescence-Based Serum Bactericidal Assay (L-SBA) to Determine Functionality of Human Sera against Shigella flexneri.
2022 · External reference
Determination of complement-mediated killing of bacteria by viability staining and bioluminescence
10.1128/aem.64.2.515-519.1998 · 1998 · External reference
Characterization of Escherichia coli bloodstream isolates associated with mortality
10.1099/jmm.0.000200 · 2016 · External reference
Innate immune evasion of Escherichia coli clinical strains from orthopedic implant infections
10.1007/s10096-016-2628-6 · 2016 · External reference
Serum resistance among Escherichia coli strains causing urinary tract infection in relation to O type and the carriage of hemolysin, colicin, and antibiotic resistance determinants
10.1128/iai.35.1.270-275.1982 · 1982 · External reference
Serum response of Escherichia coli strains causing dyspepsia and urinary tract infection: relation to alpha-hemolysin production and O type
10.1128/iai.63.11.4543-4545.1995 · 1995 · External reference
Protective role of complement in experimental Escherichia coli endocarditis
10.1128/iai.16.1.213-217.1977 · 1977 · External reference
